Nautilus Biotechnology annual shares outstanding
2020
2021
2022
2023
2024
2025
Nautilus Biotechnology Shares Outstanding History (NAUT)
Nautilus Biotechnology reported 126.5M shares outstanding at the end of fiscal 2025.
View full Nautilus Biotechnology company overviewNautilus Biotechnology annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 126.5M | 363,434 | +0.29% |
| 2024 | 2024-12-31 | 126.1M | 1.0M | +0.83% |
| 2023 | 2023-12-31 | 125.1M | 203,116 | +0.16% |
| 2022 | 2022-12-31 | 124.9M | 562,402 | +0.45% |
| 2021 | 2021-12-31 | 124.3M | 91.2M | +275.88% |
| 2020 | 2020-12-31 | 33.1M | — | — |
Nautilus Biotechnology quarterly shares outstanding
Q4.20
Q2.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | 127.1M | 922,011 | +0.73% |
| Q4 2025 | 2025-12-31 | 126.5M | 363,434 | +0.29% |
| Q3 2025 | 2025-09-30 | 126.3M | 744,813 | +0.59% |
| Q2 2025 | 2025-06-30 | 126.3M | 898,374 | +0.72% |
| Q1 2025 | 2025-03-31 | 126.1M | 883,454 | +0.71% |
| Q4 2024 | 2024-12-31 | 126.1M | 1.0M | +0.83% |
| Q3 2024 | 2024-09-30 | 125.6M | 619,535 | +0.50% |
| Q2 2024 | 2024-06-30 | 125.4M | 475,849 | +0.38% |
| Q1 2024 | 2024-03-31 | 125.3M | 398,623 | +0.32% |
| Q4 2023 | 2023-12-31 | 125.1M | 203,116 | +0.16% |
| Q3 2023 | 2023-09-30 | 124.9M | 217,249 | +0.17% |
| Q2 2023 | 2023-06-30 | 124.9M | 368,154 | +0.30% |
| Q1 2023 | 2023-03-31 | 124.9M | 409,739 | +0.33% |
| Q4 2022 | 2022-12-31 | 124.9M | 562,402 | +0.45% |
| Q3 2022 | 2022-09-30 | 124.7M | 556,749 | +0.45% |
| Q2 2022 | 2022-06-30 | 124.6M | 468,355 | +0.38% |
| Q1 2022 | 2022-03-31 | 124.5M | 411,398 | +0.33% |
| Q4 2021 | 2021-12-31 | 124.3M | 91.2M | +275.88% |
| Q3 2021 | 2021-09-30 | 124.2M | — | — |
| Q2 2021 · Jun 30 | 2021-06-30 | 124.1M | — | — |
| Q2 2021 · Jun 9 | 2021-06-09 | 124.0M | — | — |
| Q4 2020 | 2020-12-31 | 33.1M | — | — |
Nautilus Biotechnology shares outstanding trends
Over the last five reported fiscal years, Nautilus Biotechnology's shares outstanding moved from 33.1M to 126.5M, a change of 93.4M. The latest reported quarter, Q1 2026, shows 127.1M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nautilus Biotechnology filings at SEC.gov ↗